Piramal Critical Care
Andrew Bohan is a seasoned finance professional with extensive experience in tax and compliance management. Currently, Andrew serves as the Manager of Accounts, Tax & Compliance at Piramal Critical Care Inc. since August 2019, overseeing tax reporting, audits, compliance, and financial statement recognition. Prior to this role, Andrew was a Tax and Compliance Analyst at Piramal Critical Care from August 2019 to October 2021, engaging in various financial analyses and reporting tasks. Before joining Piramal, Andrew worked in accounting at Dräger from April 2012 to August 2019. Andrew holds a Master of Science in Analytics from Northeastern University and a Bachelor of Science in Accounting and Finance from Strayer University.
Piramal Critical Care
Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. Our products include Sevoflurane, Desflurane, Isoflurane, Halothane, Gablofen® (Baclofen Injection), MITIGO™(Morphine Sulfate), Dipidolor® (Piritramide), Sublimaze® (Fentanyl Citrate), Rapifen® (Alfentanil Hydrochloride), Sufenta® (Sufentanil Citrate), Hypnomidate®(Etomidate), Ampicillin and Sulbactam for Injection, USP, Cefepime for Injection, USP, Ceftriaxone for Injection, USP, Linezolid Injection, Ampicillin for Injection, USP, Piperacillin and Tazobactam for Injection, USP, Yargesa™ (Miglustat), Glycopyrrolate, Haemaccel, Rocuronium Bromide Injection, Succinylcholine Chloride Injection, USP, Dexmedetomidine Injection, USP, Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU*) and Propofol- Lipuro emulsion for Injection or Infusion. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business. *RTU Ready to use